Researchers have been excited about the medication , a groundbreaking dual agonist showing remarkable data in early trials for weight reduction . It works by targeting two pathways : GLP-1 and GIP, https://lexieoffq645037.59bloggers.com/41116688/the-new-prospect-for-size-management